China Shineway Pharmaceutical Group (HKG:2877) recorded a turnover of 2.89 billion yuan for the nine months ended Sept. 30, down 16.9% from the year-ago period, a Friday filing said.

The pharmaceutical company's injection, soft capsule, granule, and TCM formula granule products accounted for around 35.6%, 13.5%, 15.8%, and 28.5%, respectively, of the total turnover.

The company's shares were down over 1% in recent trade.